We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$207M
AUM Growth
-$43.5M
Cap. Flow
-$40.8M
Cap. Flow %
-19.76%
Top 10 Hldgs %
40.41%
Holding
113
New
16
Increased
29
Reduced
21
Closed
26

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.73M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$1.62M
3
LFCR icon
Lifecore Biomedical
LFCR
+$1.61M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.18M
5
BIDU icon
Baidu
BIDU
+$1.12M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$4.96M
2
BABA icon
Alibaba
BABA
+$4.59M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.16M
4
TPB icon
Turning Point Brands
TPB
+$2.04M
5
AMGN icon
Amgen
AMGN
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 35.36%
2 Technology 18.94%
3 Communication Services 8.24%
4 Consumer Discretionary 5.11%
5 Financials 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MU icon
1
Micron Technology
MU
$930B
$15.4M 7.47%
183,500
+7,000
+4% +$712K
ARGX icon
2
argenx
ARGX
$53.4B
$12.3M 5.95%
20,000
– –
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.36T
$10.9M 5.29%
57,400
-12,250
-18% -$2.16M
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.33M 4.03%
99,757
-750
-0.7% -$61.6K
AMZN icon
5
Amazon
AMZN
$2.92T
$6.58M 3.18%
30,000
-4,500
-13% -$921K
REGN icon
6
Regeneron Pharmaceuticals
REGN
$78.5B
$6.34M 3.07%
8,900
+1,150
+15% +$965K
ORCL icon
7
Oracle
ORCL
$374B
$6.08M 2.94%
36,500
+1,500
+4% +$266K
AMD icon
8
Advanced Micro Devices
AMD
$776B
$6.04M 2.92%
50,000
+12,000
+32% +$1.73M
ABBV icon
9
AbbVie
ABBV
$443B
$5.6M 2.71%
31,500
+500
+2% +$91.9K
LLY icon
10
Eli Lilly
LLY
$1.02T
$5.4M 2.61%
7,000
– –
VOO icon
11
PUT
Vanguard S&P 500 ETF
VOO
$979B
$5.39M 2.61%
10,000
-79,600
-89% -$43.1M
BAC icon
12
Bank of America
BAC
$435B
$5.25M 2.54%
119,500
– –
IAU icon
13
iShares Gold Trust
IAU
$62.9B
$4.95M 2.4%
100,000
– –
XNCR icon
14
Xencor
XNCR
$1.5B
$4.67M 2.26%
203,167
-6,312
-3% -$145K
GLD icon
15
SPDR Gold Trust
GLD
$131B
$4.36M 2.11%
18,000
– –
BIDU icon
16
Baidu
BIDU
$37.7B
$4.03M 1.95%
47,750
+12,250
+35% +$1.12M
LFCR icon
17
Lifecore Biomedical
LFCR
$166M
$4.01M 1.94%
539,989
+251,511
+87% +$1.61M
SLV icon
18
iShares Silver Trust
SLV
$28B
$3.82M 1.85%
145,000
-4,500
-3% -$129K
INCY icon
19
Incyte
INCY
$24.2B
$3.35M 1.62%
48,500
+250
+0.5% +$17.8K
TEVA icon
20
Teva Pharmaceuticals
TEVA
$40.8B
$3.25M 1.57%
147,500
+34,500
+31% +$628K
C icon
21
Citigroup
C
$222B
$3.17M 1.53%
45,000
+7,500
+20% +$505K
IONS icon
22
Ionis Pharmaceuticals
IONS
$8.6B
$2.9M 1.4%
82,882
+43,382
+110% +$1.62M
GDX icon
23
VanEck Gold Miners ETF
GDX
$22.7B
$2.8M 1.35%
82,500
+7,500
+10% +$288K
ZBH icon
24
Zimmer Biomet
ZBH
$18.2B
$2.41M 1.17%
22,819
-500
-2% -$53.6K
IWM icon
25
iShares Russell 2000 ETF
IWM
$79.8B
$2.38M 1.15%
10,750
– –
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, DCF Advisers held 113 positions worth $207M, down 17% from $250M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

DCF Advisers withdrew a net $40.8M in Q4 2024, closing 26 positions and reducing 21 holdings. Its most notable exit was Energy Transfer Partners, an estimated $4.96M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers added an estimated $1.73M to Advanced Micro Devices.

  • DCF Advisers added most to Advanced Micro Devices in Q4 2024, an estimated $1.73M increase.
  • DCF Advisers's biggest Q4 2024 reduction was Alphabet (Google) Class C, cutting an estimated $2.16M.
  • DCF Advisers fully exited Energy Transfer Partners in Q4 2024, selling an estimated $4.96M.
  • DCF Advisers's ten largest holdings make up 40% of its $207M portfolio in Q4 2024.
  • DCF Advisers opened 16 new positions and closed 26 in Q4 2024.
  • DCF Advisers's portfolio value fell 17% quarter-over-quarter to $207M.

Based on DCF Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.